Singapore markets close in 7 hours 46 minutes
Straits Times Index
3,293.13 0.00 (0.00%) Nikkei
37,988.51 -471.57 (-1.23%) Hang Seng
17,201.27 +372.34 (+2.21%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,511.64 -2,257.67 (-3.38%) CMC Crypto 200
1,394.85 -29.25 (-2.05%)
ABBV Jan 2025 150.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:19PM EDT. Market open.
| Previous close | 5.15 |
| Open | 5.10 |
| Bid | 5.00 |
| Ask | 5.35 |
| Strike | 150.00 |
| Expiry date | 2025-01-17 |
| Day's range | 5.10 - 5.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 4.65k |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
© 2024 Yahoo. All rights reserved.